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Original Article
Wound infiltration with Bupivacaine versus Ketorolac for postoperative
pain relief in minor to moderate surgeries
Mohammad Irfan Akhtar,1 Mohammad Saleem,2 Jawad Zaheer3

Anaesthesia Department, Aga Khan University Hospital, Karachi,1 Anaesthesia Department, Railway Hospital Rawalpindi,2
Anaesthesia Department, Holy Family Hospital Rawalpindi.3

Abstract

Objective: To compare the analgesic efficacy of Bupivacaine 0.25% wound infiltration with Ketorolac incisional
infiltration in relieving postoperative pain for first twenty-four hours.
Methodology: Analytical, interventional and comparative study was performed on seventy patients, of both
sexes, with varied age groups. Patients underwent minor and moderate surgeries, confined to American Society
of Anaesthesiologist ASA category 1-II. Patients were selected by convenience sampling and were divided into
two groups i.e. Group I and Group II. Group-I comprised of thirty five patients and were infiltrated with
Bupivacaine 0.25% at wound margins postoperatively. Group-II also comprised of thirty-five patients and were
infiltrated with Ketorolac at wound margins 60mg postoperatively.
Results: Bupivacaine 0.25% wound infiltration had onset of action within 4±2 minutes. Percentage pain relief
was 80% in minor surgeries and 60% in moderate surgeries. Duration of action lasted for 8±2 hours regarding
minor surgeries while it was 6±1 hours for moderate surgeries. Ketorolac incisional infiltration had onset of
analgesic action within 10±5 minutes. Duration of action lasted for 6±1 hours regarding minor surgeries while it
was 4±2 hours regarding moderate surgeries. Percentage pain relief was 60% in minor surgeries and 50% in
moderate surgeries.
Conclusion: Wound infiltration with Bupivacaine 0.25% was better for postoperative pain relief in comparison
with Ketorolac regarding percentage pain relief, onset and duration of action (JPMA 59:385; 2009).

Introduction

Pain is a complex but an important protective
phenomenon. It may be defined as an unpleasant
sensory and emotional experience associated with
actual or potential tissue damage or described in terms
of such damage. 1 Good postoperative pain relief is
important as it alleviates patient's distress and helps in
rapid uncomplicated recovery. It also reduces the stress
response to surgery, which is very important for
patients with compromised cardiovascular respiratory
functions.
Pain has been a constant companion of the human
race since time immemorial. To alleviate their suffering
people tried different methods, one of them being
chewing leaves of different plants for their analgesic
effects. One of the plants commonly used was the poppy,
(Papaver somniferum). Poppy is the source of opium, the
crude substance and morphine, its purified constituent.
The plant may have been in use for over 6000 years and
there are accounts of its use in ancient Egyptian, Greek
and Roman documents.2

Acetylsalicylic acid was synthesized in 1853, but
the drug was not used until 1899, when it was found to be
effective in arthritis and well tolerated. It was named
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'Aspirin'. Because of its greater efficacy and low cost.
Aspirin rapidly replaced the natural products then in use
and has remained one of the most widely employed
remedies for over 90 years. Since the last few years the
medical profession has come to the conclusion that its
capacity for providing adequate analgesia is severely
flawed. The publication of the Joint Colleges Report on
'Pain After Surgery' came not only as a hearty shock, but
also served to encourage many, especially
anaesthesiologists, to pay attention to the shortcomings
of analgesia and pain relief services, at least in the acute,
post surgical area.3 Advances have been made in pain
management due to better understanding of the
physiology, biochemistry, the genetics of pain, and better
knowledge about the analgesic agents. The alleviation of
postoperative pain is primarily provided for humanitarian
reasons and to reduce nociception-induced responses,
which may adversely influence organ functioning and
contribute to morbidity.4
Pain is a subjective phenomenon, which may be
described in terms of its location, intensity, duration and
its impact on the sufferer. After surgery, patient may
complain directly related to the site of surgery or
coincidentally from other sites. Spontaneous or forced
movement may precipitate pain from parietal tissues, as
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for example by coughing or deep breathing following
abdominal surgery.
The purpose of the study was to compare the
analgesic efficacy of Bupivacaine 0.25% with ketorolac
wound infiltration in minor to moderate surgeries.

Operational Definitions:

Analgesic efficacy: Analgesic efficacy is defined in
terms of onset of action, duration of action and
percentage pain relief.
Minor surgeries: Henia repairs, Appendicectomies.

Moderate surgeries: C-Sections,Cholecystectomies.
ASA-I: Fit healthy patient.

ASA-II: A patient with mild systemic disease and no
functional limitation.

Patients and Methods

This analytical, interventional and comparative
study was conducted at a tertiary care hospital, after
approval from the ethical committee of the hospital.
Informed written consent was taken from all the patients
included in the study.
Inclusion Criteria were, ASA I-II patients
undergoing elective or emergency minor to moderate
surgeries and different age groups (20-50 years)
belonging to both sexes.

The Exclusion Criteria were, patients allergic to
amide local anaesthetics and patients having history of
acid peptic disease, renal dysfunction and bleeding
diasthesis.
A total of seventy patients were selected by
convenience sampling, who had to undergo minor to
moderate surgeries. All were randomly allocated to the
two groups ( group I and group II). Both anaesthetist and
surgeon were blinded to the infiltration solution.Only the
staff nurse knew the group and the solution to be
infiltrated .The infiltration solution composition and
volume is described below.

Group I: Thirty five patients were included in this
group. These patients were infiltrated with injection
Bupivacaine 0.25% (diluted in 7.5 ml saline to make a
volume of 15ml) at the wound margins at the end of
surgery.

Group II: Thirty five patients were included in this
group. These patients were infiltrated with injection
Ketorolac 60mg (diluted in 13ml saline to make volume
of 15 mls) at the wound margins at the end of surgery.
All the patients were assessed preoperatively and
were explained about the analgesic technique to be
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employed postoperatively. They were premedicated with
Tab midazolam 7.5mg per oral half an hour before
coming to operating room. All patients were given
general anaesthesia after establishment of mandatory
monitoring (ECG, NIBP, SPO2., Temperature). Same
general anaesthetic technique was adopted in all the
patients. After preoxygenation with 100 % O2, patients
were induced with pentothal 4-5 mg/kg, fentanyl 2-3
mics/ kg and were intubated with succinylcholine.
Lignocaine 1-1.5 mg/kg I/V was used to blunt the
intubation response. Rapid sequence technique was used
for emergency and C-sections.Anaesthesia was
maintained with isoflorane and O2 (30%) nitrous cxide
(70%) mixture and increments of atracurium. All were
infiltrated with 1% xylocaine at the wound margins for
intraoperative pain relief prior to incision. An indwelling
catheter was placed between the wound layers to allow
intermittent infiltration of the wound in the
postoperative period for 24 hours. These patients were
assessed for pain in the ward, and analgesia was given in
the form of wound infiltration (either Bupivacaine for
Group-I patients and ketorolac for Group-II patients)
through indwelling catheter when the pain score was
more than 1 on the pain score proforma. The extent of
pain, time of onset of analgesic action, percentage pain
relief and duration of analgesic action was recorded on
the pain assessment proforma. The parameters used to
assess the onset of analgesia were subjective feeling of
pain and objective parameters like heart rate, blood
pressure and respiratory rate. Sleep pattern was also
included as criteria for percentage pain relief i.e. patient
sleep pattern altered means moderate pain and inability
to sleep indicates severe pain, as shown on the attached
proforma.
Injection tramadol 50mg I/V was used as rescue
analgesia. These two groups were compared with respect
to the onset of analgesia, duration of analgesia,
percentage pain relief, age, sex and type of surgery
(whether minor or moderate).

Data Analysis Procedure:

SPSS version 16 was used and Chi-square test was
applied to draw our results about analgesic efficacy with
the two groups. A p value < .05 was taken as statistically
significant.

Results

After comparing the drugs of two groups with
respect to onset and duration of action, it was found that
onset of action was quicker with Bupivacaine 0.25%
wound infiltration i.e. within 4±2 minutes and duration
of action varied according to type of surgery. In cases of
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minor surgeries, the duration of action was 8±2 hours,
and in case of moderate surgeries duration of action was
6±1 hour. In group-II patients infiltrated with ketorolac,
the onset of action was 10±5 minutes. Duration of action
varied according to type of surgery. Patients undergoing
minor surgeries remained pain free for 6±1 hour and
those undergoing moderate surgeries were relieved of
pain for 4±2 hours.

Pain relief was also better with Bupivacaine
0.25% i.e. 80% in minor surgeries and 60% in moderate
surgeries. Regarding ketorolac, percentage pain relief
was 60% for minor surgeries and 50% for moderate
surgeries. The average consumption of Bupivacain was
three to four ampules and for ketorolac it was 8-10
ampules.Cost of one ampule of bupivacaine and
ketorolac is 19 Rs and 90 Rs respectively. Over twenty
four hours,average consumption of bupivacaine was two
to three ampules while for ketorolac it was four to five
ampules (120-150mg), depending upon whether surgery
was minor or moderate respectively. The maximum safe
dose of bupivacaine is 1-1.5mg/kg.
Regarding the rescue analgesia usage there was no
statistical difference.

Female patients were more sensitive to pain. The
pain score for female patients was 3±0.5, while it was
2.5±0.5 for male patients on the proforma. Bupivacaine
was found to be more effective regarding percentage pain
relief, onset and duration of analgesia. Economically it
was also accepted for two reasons, it was cheaper than
ketorolac and less number of injections were needed for
infiltration.
By applying chi-square test to our results about
analgesic efficacy with the two groups, it was observed
that Bupivacaine infiltration produced better pain relief
as compared to ketorolac (P < 0.05).

Discussion

The methods of pain scoring include Verbal
Rating Scale (VRSs), numerical rating scales (NRSs),
visual analogue scales (VASs), and method used most
commonly in Pakistan, the Pakistan Coin Pain Scale
(PCPS). 5 These simple methods have been used
effectively in hospital clinics and have provided valuable
information about pain and analgesia.

Bupivacaine is a long acting local anaesthetic
belonging to amide group. Maximum safe dose is 1.5 - 2
mg per kg body weight.
Toxicity is related to plasma level of unbound
drug and is most likely to be seen after intra vascular
injection. Appearance of convulsions may be the first
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sign of toxicity under such circumstanses.
Cardiovascular toxicity is usually preceded by evidence
of hypoxia associated with apnoea due to central
depression, but some times fibrillation. Due to
Bupivacaine high protein binding capacity, cardiac
resuscitation is difficult due to strong binding with
sodium channels in myocardial muscle.
The use of wound infiltration for postoperative
pain relief is an attractive method because of the apparent
simplicity, safety and low cost. For incisional analgesia
either local anaesthetics or NSAIDs may be used.

In a recent qualitative systematic review 26
appropriately randomized and double-blind trials
comparing incisional local anaesthetics with placebo or
no treatment were identified using the Medline and
Cochrane databases 1966-1997 and 1997 respectively
and bibliographs of retrieved reports.6

All trials of hernia repair comparing
Bupivacaine 0.25-0.5% 15-40ml, lidocaine 200mg, and
Bupivacaine 0.25-0.5% 40 ml with placebo or no
treatment, showed improved postoperative pain relief,
as pain scores and analgesic consumption were reduced
by 25-50% in all trials and time to first analgesic
request was prolonged between 2-7 hours.
Subsequently, a further two trials of Bupivacaine 0.250.75%, 30-40ml 7,8 and one trial of continuous intrawound infusion of Bupivacaine 0.5% 9 have confirmed
the positive results from the review.

In a systematic review of peripheral local
anaesthetics after laparoscopic surgery port-site
infiltration for postoperative pain relief was investigated
in eight trials.10 The NSAIDs mainly act peripherally
because entry into the CNS is limited for most NSAIDs
due to their protein binding, their polar nature and
consequent low lipophilicity. A recent study has shown
that opioid potentiation of descending inhibitory GABA
nergic influences on nociceptive pathways in the midbrain peri-aqueductal grey matter may itself be enhanced
further by NSAIDs.11
Hence it is quite evident from the study that local
infiltration either with local anaesthetic or some NSAID
should be the part and parcel of the multimodel
intraoperative and postoperative pain management.

Conclusion

Wound infiltration with Bupivacaine 0.25% was
better than ketorolac incisional infiltration in relieving
postoperative pain for first 24 hours because Bupivacaine
had earlier onset, longer duration of action and better
pain relief .It was also cost effective in comparison with
Ketorolac.
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